541 related articles for article (PubMed ID: 33526559)
21. The Intestinal Epithelium: Central Coordinator of Mucosal Immunity.
Allaire JM; Crowley SM; Law HT; Chang SY; Ko HJ; Vallance BA
Trends Immunol; 2018 Sep; 39(9):677-696. PubMed ID: 29716793
[TBL] [Abstract][Full Text] [Related]
22. Elevated colonic microbiota-associated paucimannosidic and truncated N-glycans in pediatric ulcerative colitis.
Li H; Zhang X; Chen R; Cheng K; Ning Z; Li J; Twine S; Stintzi A; Mack D; Figeys D
J Proteomics; 2021 Oct; 249():104369. PubMed ID: 34481999
[TBL] [Abstract][Full Text] [Related]
23. Association among genetic predisposition, gut microbiota, and host immune response in the etiopathogenesis of inflammatory bowel disease.
Basso PJ; Fonseca MT; Bonfá G; Alves VB; Sales-Campos H; Nardini V; Cardoso CR
Braz J Med Biol Res; 2014 Sep; 47(9):727-37. PubMed ID: 25075576
[TBL] [Abstract][Full Text] [Related]
24. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis.
Rohrhofer J; Zwirzitz B; Selberherr E; Untersmayr E
Front Immunol; 2021; 12():635704. PubMed ID: 34054805
[TBL] [Abstract][Full Text] [Related]
25. Cage Environment Regulates Gut Microbiota Independent of Toll-Like Receptors.
Lipinski JH; Zhou X; Gurczynski SJ; Erb-Downward JR; Dickson RP; Huffnagle GB; Moore BB; O'Dwyer DN
Infect Immun; 2021 Aug; 89(9):e0018721. PubMed ID: 33941577
[TBL] [Abstract][Full Text] [Related]
26. Gut mucosal virome alterations in ulcerative colitis.
Zuo T; Lu XJ; Zhang Y; Cheung CP; Lam S; Zhang F; Tang W; Ching JYL; Zhao R; Chan PKS; Sung JJY; Yu J; Chan FKL; Cao Q; Sheng JQ; Ng SC
Gut; 2019 Jul; 68(7):1169-1179. PubMed ID: 30842211
[TBL] [Abstract][Full Text] [Related]
27. Intervention and potential mechanism of non-starch polysaccharides from natural resources on ulcerative colitis: A review.
Wang YJ; Li QM; Zha XQ; Luo JP
Int J Biol Macromol; 2022 Jun; 210():545-564. PubMed ID: 35513106
[TBL] [Abstract][Full Text] [Related]
28. Ethanol extract of Centella asiatica alleviated dextran sulfate sodium-induced colitis: Restoration on mucosa barrier and gut microbiota homeostasis.
Li H; Chen X; Liu J; Chen M; Huang M; Huang G; Chen X; Du Q; Su J; Lin R
J Ethnopharmacol; 2021 Mar; 267():113445. PubMed ID: 33022343
[TBL] [Abstract][Full Text] [Related]
29. Cellular and molecular immunopathogenesis of ulcerative colitis.
Zhang SZ; Zhao XH; Zhang DC
Cell Mol Immunol; 2006 Feb; 3(1):35-40. PubMed ID: 16549047
[TBL] [Abstract][Full Text] [Related]
30. Matrine protects against DSS-induced murine colitis by improving gut barrier integrity, inhibiting the PPAR-α signaling pathway, and modulating gut microbiota.
Yao H; Shi Y; Yuan J; Sa R; Chen W; Wan X
Int Immunopharmacol; 2021 Nov; 100():108091. PubMed ID: 34474274
[TBL] [Abstract][Full Text] [Related]
31. Aging Increases the Severity of Colitis and the Related Changes to the Gut Barrier and Gut Microbiota in Humans and Mice.
Liu A; Lv H; Wang H; Yang H; Li Y; Qian J
J Gerontol A Biol Sci Med Sci; 2020 Jun; 75(7):1284-1292. PubMed ID: 32048723
[TBL] [Abstract][Full Text] [Related]
32. Heterophyllin B an Active Cyclopeptide Alleviates Dextran Sulfate Sodium-Induced Colitis by Modulating Gut Microbiota and Repairing Intestinal Mucosal Barrier via AMPK Activation.
Chen C; Liang H; Wang J; Ren G; Li R; Cui ZG; Zhang C
Mol Nutr Food Res; 2022 Sep; 66(17):e2101169. PubMed ID: 35796402
[TBL] [Abstract][Full Text] [Related]
33. Metabolism at the centre of the host-microbe relationship.
Maslowski KM
Clin Exp Immunol; 2019 Aug; 197(2):193-204. PubMed ID: 31107965
[TBL] [Abstract][Full Text] [Related]
34. Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation.
Shen ZH; Zhu CX; Quan YS; Yang ZY; Wu S; Luo WW; Tan B; Wang XY
World J Gastroenterol; 2018 Jan; 24(1):5-14. PubMed ID: 29358877
[TBL] [Abstract][Full Text] [Related]
35. Schisandrin B prevents ulcerative colitis and colitis-associated-cancer by activating focal adhesion kinase and influence on gut microbiota in an in vivo and in vitro model.
Li J; Lu Y; Wang D; Quan F; Chen X; Sun R; Zhao S; Yang Z; Tao W; Ding D; Gao X; Cao Q; Zhao D; Qi R; Chen C; He L; Hu K; Chen Z; Yang Y; Luo Y
Eur J Pharmacol; 2019 Jul; 854():9-21. PubMed ID: 30951716
[TBL] [Abstract][Full Text] [Related]
36. Glucagon-like peptide (GLP) -2 improved colonizing bacteria and reduced severity of ulcerative colitis by enhancing the diversity and abundance of intestinal mucosa.
Li D; Yang Y; Yin X; Liu Y; Xu H; Ni Y; Hang P; Niu S; Zhang H; Ding W; Kuang H
Bioengineered; 2021 Dec; 12(1):5195-5209. PubMed ID: 34402720
[TBL] [Abstract][Full Text] [Related]
37. Immune and genetic gardening of the intestinal microbiome.
Jacobs JP; Braun J
FEBS Lett; 2014 Nov; 588(22):4102-11. PubMed ID: 24613921
[TBL] [Abstract][Full Text] [Related]
38. Potent Intestinal Mucosal Barrier Enhancement of
Guo M; Xing D; Wang J; Zhang Y; Li Z; Jiao X
Nutrients; 2023 Jul; 15(13):. PubMed ID: 37447380
[TBL] [Abstract][Full Text] [Related]
39. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
[TBL] [Abstract][Full Text] [Related]
40. Kaempferol Alleviates Murine Experimental Colitis by Restoring Gut Microbiota and Inhibiting the LPS-TLR4-NF-κB Axis.
Qu Y; Li X; Xu F; Zhao S; Wu X; Wang Y; Xie J
Front Immunol; 2021; 12():679897. PubMed ID: 34367139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
